JPL Wealth Management »

Avita Therapeutics shares owned by JPL Wealth Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by JPL Wealth Management from 13F filings

Historical chart of JPL Wealth Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by JPL Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by JPL Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $19 5 3.80
2025-09-30 $26 5 5.20

More positions owned by JPL Wealth Management

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Broadcom (AVGO)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ea Series Trust Alpha Architect (CAOS)
Alphabet Cap Stk Cl A (GOOGL)
Ea Series Trust Alpha Architect (AAEQ)
UnitedHealth (UNH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Chevron Corporation (CVX)
Caterpillar (CAT)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for JPL Wealth Management

Top funds holding Avita Therapeutics

OrbiMed Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Geode Capital Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Morgan Stanley
Bridgeway Capital Management
Divisadero Street Capital Management
Goldman Sachs Group
AQR Capital Management
Goss Wealth Management
Vanguard Portfolio Management

View all funds holding Avita Therapeutics